Remick et al HIV Infection and Heart Failure 1783 with LV systolic dysfunction (n= 148;
29%), and 196 (38%) had HIV-related cardiomyopathy (which encompassed both systolic …

From a global perspective, cardiovascular disease (CVD) in human immunodeficiency virus
(HIV) may result from cardiac involvement upon presentation of opportunistic infections in …

Objective: To evaluate the types and mechanisms of stroke in a large population of HIV-
infected patients. Methods: We reviewed records of consecutive HIV-infected patients with …

Aims Human immunodeficiency virus infection (HIV) has been associated with cardiac
dysfunction that, if present, can negatively affect morbidity and mortality of HIV-infected …

Cardiomyopathy in AIDS is an increasingly important clinical problem. Mechanisms of AIDS
cardiomyopathy were explored using AIDS transgenic mice that express replication …

Although cardiotoxic effects of highly active antiretroviral therapy (HAART) are a growing
concern, there is a lack of prospective studies of subclinical involvement of the heart in …

Introduction: Cardiovascular abnormalities are common in HIV-infected patients, although
often clinically quiescent. This study sought to identify by echocardiography early …

Historically, advanced heart failure therapies were considered inappropriate for patients
infected with human immunodeficiency virus (HIV). As HIV has become a chronic illness with …

With improved and highly active antiretroviral therapy (HAART) the average life span of HIV
infected individuals has increased tremendously. HIV infections can now be managed with …

Objective: To establish the relationship between HIV-induced cardiac diastolic dysfunction,
immune responses, and virus replication in the heart using the simian immunodeficiency …